Although prostate-specific membrane antigen (PSMA) imaging is the gold standard for lymph node staging in prostate cancer, its sensitivity varies according to lymph node size and Prostasti Specific Antigen (PSA) level. Here, FOLH1 is linked to prostate carcinoma.